{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:49:51Z","timestamp":1793836191226,"version":"4.6.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.beem.2023.101851","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T17:40:05Z","timestamp":1701366005000},"page":"101851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The pathophysiology of hypophosphatemia"],"prefix":"10.1016","volume":"38","author":[{"given":"Nobuaki","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2023.101851_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00223-020-00659-6","article-title":"Congenital hyperphosphatemic conditions caused by the deficient activity of FGF23","volume":"108","author":"Ito","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2023.101851_bib2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.eprac.2022.07.005","article-title":"Hypophosphatemia: a practical guide to evaluation and management","volume":"28","author":"Tebben","year":"2022","journal-title":"Endocr Pr"},{"key":"10.1016\/j.beem.2023.101851_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"White","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2023.101851_bib4","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2023.101851_bib5","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1681\/ASN.2014030317","article-title":"Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in CKD","volume":"26","author":"Labont\u00e9","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2023.101851_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bone.2012.07.014","article-title":"New insights into NPP1 function: lessons from clinical and animal studies","volume":"51","author":"Mackenzie","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.beem.2023.101851_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2023.101851_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/ph14040289","article-title":"Matrix vesicles: role in bone mineralization and potential use as therapeutics","volume":"14","author":"Ansari","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.beem.2023.101851_bib9","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.celrep.2013.05.035","article-title":"Inorganic phosphate export by the retrovirus receptor XPR1 in metazoans","volume":"3","author":"Giovannini","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2023.101851_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2016070726","article-title":"Renal fanconi syndrome and hypophosphatemic rickets in the absence of xenotropic and polytropic retroviral receptor in the nephron","volume":"28","author":"Ansermet","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2023.101851_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ng.1077","article-title":"Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis","volume":"44","author":"Wang","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2023.101851_bib12","doi-asserted-by":"crossref","first-page":"F691","DOI":"10.1152\/ajprenal.90623.2008","article-title":"The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi","volume":"296","author":"Villa-Bellosta","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.beem.2023.101851_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/jbmr.061105","article-title":"Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23","volume":"22","author":"Frishberg","year":"2007","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2023.101851_bib14","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2023.101851_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2014.10.007","article-title":"Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli","volume":"399","author":"Ito","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2023.101851_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2023.101851_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/427956","article-title":"Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation","volume":"76","author":"White","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2023.101851_bib18","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1096\/fj.10-177816","article-title":"Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling","volume":"25","author":"Martin","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.beem.2023.101851_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.beem.2023.101851_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1200\/JCO.2016.67.2048","volume":"35","author":"Nogova","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beem.2023.101851_bib21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jcb.25742","article-title":"Extracellular phosphate induces the expression of dentin matrix protein 1 through the FGF receptor in osteoblasts","volume":"118","author":"Nishino","year":"2017","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.beem.2023.101851_bib22","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1073\/pnas.1815166116","article-title":"Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation","volume":"166","author":"Takashi","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2023.101851_bib23","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.beem.2023.101851_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","article-title":"Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans","volume":"25","author":"Ito","year":"2007","journal-title":"J Bone Min Metab"},{"key":"10.1016\/j.beem.2023.101851_bib25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101851_bib26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.beem.2023.101851_bib27","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1210\/clinem\/dgab635","article-title":"Acute effects of an inorganic phosphorus additive on mineral metabolism and cardiometabolic risk factors in healthy subjects","volume":"107","author":"Volk","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101851_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eprac.2022.09.007","article-title":"Phosphatonins: from discovery to therapeutics","volume":"29","author":"Kritmetapak","year":"2023","journal-title":"Endocr Pr"},{"key":"10.1016\/j.beem.2023.101851_bib29","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1530\/JME-20-0178","article-title":"FGF23 signalling and physiology","volume":"66","author":"Ho","year":"2021","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.beem.2023.101851_bib30","doi-asserted-by":"crossref","first-page":"25134","DOI":"10.1074\/jbc.M110.132423","article-title":"Cooperativity between the phosphorylation of Thr95 and Ser77 of NHERF-1 in the hormonal regulation of renal phosphate transport","volume":"285","author":"Weinman","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.beem.2023.101851_bib31","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10157-019-01725-6","article-title":"Role of the putative PKC phosphorylation sites of the type IIc sodium-dependent phosphate transporter in parathyroid hormone regulation","volume":"23","author":"Fujii","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.beem.2023.101851_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12399-9","article-title":"Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion","volume":"10","author":"Centeno","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2023.101851_bib33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician\u2019s guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2023.101851_bib34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bone.2019.06.025","article-title":"Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients","volume":"127","author":"DeLacey","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.beem.2023.101851_bib35","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jbmr.3992","article-title":"Hyperparathyroidism in Patients With X-Linked Hypophosphatemia","volume":"35","author":"Lecoq","year":"2020","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2023.101851_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.0.1510055","article-title":"Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism","volume":"151","author":"Yamashita","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2023.101851_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jc.2008-0220","article-title":"Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen\u2019s metaphyseal chondrodysplasia","volume":"94","author":"Brown","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101851_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jbmr.4429","article-title":"PTH and FGF23 exert interdependent effects on renal phosphate handling: evidence from patients with hypoparathyroidism and hyperphosphatemic familial tumoral calcinosis treated with synthetic human PTH 1-34","volume":"37","author":"Ovejero","year":"2022","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2023.101851_bib39","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2015-1483","article-title":"Duodenal expression of 25 hydroxyvitamin D3-1\u03b1-hydroxylase is higher in adolescents than in children and adults","volume":"100","author":"Gawlik","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101851_bib40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/nu15030480","article-title":"Vitamin D and bone: a story of endocrine and auto\/paracrine action in osteoblasts","volume":"15","author":"van Driel","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.beem.2023.101851_bib41","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2023.101851_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI111448","article-title":"Vitamin D deficiency and renal calcium transport in the rat","volume":"74","author":"Yamamoto","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beem.2023.101851_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2023.101851_bib44","doi-asserted-by":"crossref","first-page":"558S","DOI":"10.1093\/ajcn\/88.2.558S","article-title":"Assessing the vitamin D status of the US population","volume":"88","author":"Yetley","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.beem.2023.101851_bib45","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2337\/dc09-0209","article-title":"Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals","volume":"32","author":"Lu","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2023.101851_bib46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bone.2010.05.024","article-title":"Fibroblast growth factor 23 concentrations in healthy term infants during the early postpartum period","volume":"47","author":"Takaiwa","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.beem.2023.101851_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000506477","article-title":"Fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein levels in healthy children and, pregnant and puerperal women","volume":"92","author":"Ozsen","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.beem.2023.101851_bib48","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1210\/clinem\/dgad210","article-title":"Impaired physical performance in X-linked hypophosphatemia is not caused by depleted muscular phosphate stores","volume":"108","author":"Kara","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101851_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115055","article-title":"Elevated FGF23 in a patient with hypophosphatemic osteomalacia associated with neurofibromatosis type 1","volume":"129","author":"Sahoo","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.beem.2023.101851_bib50","first-page":"3","article-title":"Dual paraneoplastic syndromes in a patient with small cell lung cancer: a case report","volume":"5","author":"Coners","year":"2011","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.beem.2023.101851_bib51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1066896915617828","article-title":"FGF23-associated tumor-induced osteomalacia in a patient with small cell carcinoma: a case report and regulatory mechanism study","volume":"24","author":"Sauder","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.beem.2023.101851_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bcr-2014-206590","article-title":"Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: Is Klotho involved?","volume":"2014","author":"Latifyan","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.beem.2023.101851_bib53","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/jbmr.4620","article-title":"Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance","volume":"37","author":"Hidaka","year":"2022","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2023.101851_bib54","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","article-title":"Hypophosphatemia induced by intravenous administration of saccharated ferric oxide","volume":"45","author":"Shimizu","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.beem.2023.101851_bib55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1258\/acb.2008.008151","article-title":"Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia","volume":"46","author":"Schouten","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.beem.2023.101851_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124486","article-title":"Randomized trial of intravenous iron-induced hypophosphatemia","volume":"3","author":"Wolf","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.beem.2023.101851_bib57","article-title":"Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption","volume":"15","author":"Hidaka","year":"2021","journal-title":"Bone Rep"},{"key":"10.1016\/j.beem.2023.101851_bib58","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.ki.5001788","article-title":"Post-transplant hypophosphatemia: tertiary \u201chyper-phosphatoninism\u201d?","volume":"70","author":"Bhan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2023.101851_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10157-007-0489-0","article-title":"Persistent high level of fibroblast growth factor 23 as a cause of post-renal transplant hypophosphatemia","volume":"11","author":"Kawarazaki","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.beem.2023.101851_bib60","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1210\/clinem\/dgz260","article-title":"Mutation of SGK3, a novel regulator of renal phosphate transport, causes autosomal dominant hypophosphatemic rickets","volume":"105","author":"Cebeci","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101851_bib61","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-015-0184-4","article-title":"A case of severe osteomalacia caused by tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis","volume":"16","author":"Yamaguchi","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.beem.2023.101851_bib62","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1681\/ASN.2016101074","article-title":"Tubulointerstitial nephritis with IgM-positive plasma cells","volume":"28","author":"Takahashi","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2023.101851_bib63","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","article-title":"Fanconi syndrome and renal failure induced by tenofovir: a first case report","volume":"40","author":"Verhelst","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2023.101851_bib64","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/j.ajkd.2009.03.013","article-title":"Fanconi syndrome due to deferasirox","volume":"54","author":"Rafat","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2023.101851_bib65","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jbmr.522","article-title":"A case of hypophosphatemic osteomalacia secondary to deferasirox therapy","volume":"27","author":"Milat","year":"2012","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2023.101851_bib66","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2002-020249","article-title":"A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor","volume":"88","author":"Kifor","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101851_bib67","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa040008","article-title":"Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor","volume":"351","author":"Pallais","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2023.101851_bib68","doi-asserted-by":"crossref","first-page":"E3682","DOI":"10.1210\/clinem\/dgab282","article-title":"Incidence of Complications in 25 Adult Patients with X-linked Hypophosphatemia","volume":"106","author":"Kato","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101851_bib69","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1210\/en.2012-1551","article-title":"Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice","volume":"153","author":"Karaplis","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2023.101851_bib70","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bone.2011.06.029","article-title":"A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene","volume":"49","author":"Saito","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.beem.2023.101851_bib71","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1210\/clinem\/dgac732","article-title":"Effect of conventional treatment on dental complications and ectopic ossifications among 30 adults with XLH","volume":"108","author":"Kato","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101851_bib72","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101851_bib73","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2023.101851_bib74","article-title":"Clinical performance of a new intact FGF23 immunoassay in healthy individuals and patients with chronic hypophosphatemia","volume":"18","author":"Kato","year":"2023","journal-title":"Bone Rep"},{"key":"10.1016\/j.beem.2023.101851_bib75","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2023.101851_bib76","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2023.101851_bib77","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of Burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2023.101851_bib78","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jbmr.4184","article-title":"Interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia","volume":"36","author":"Imanishi","year":"2021","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2023.101851_bib79","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2023.101851_bib80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ki.2011.67","article-title":"Decreased bone density and increased phosphaturia in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase 3","volume":"80","author":"Bhandaru","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2023.101851_bib81","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI98680","article-title":"CYP3A4 mutation causes vitamin D-dependent rickets type 3","volume":"128","author":"Roizen","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beem.2023.101851_bib82","unstructured":"World Health Organization. Nutritional rickets: a review of disease burden, causes, diagnosis, prevention and treatment. \u3008https:\/\/www.who.int\/publications\/i\/item\/9789241516587\u3009 [Accessed 6 November 2023]."},{"key":"10.1016\/j.beem.2023.101851_bib83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12098-009-0289-5","article-title":"Primary hyperparathyroidism in children and adolescents","volume":"77","author":"George","year":"2010","journal-title":"Indian J Pedia"},{"key":"10.1016\/j.beem.2023.101851_bib84","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00268-020-05816-4","article-title":"Pediatric primary hyperparathyroidism: experience in a tertiary care referral center in a developing country over three decades","volume":"45","author":"Sharanappa","year":"2021","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2023.101851_bib85","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jpedsurg.2014.05.032","article-title":"Surgical treatment of children with hyperparathyroidism: single centre experience","volume":"49","author":"Alagaratnam","year":"2014","journal-title":"J Pedia Surg"},{"key":"10.1016\/j.beem.2023.101851_bib86","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/cen.13453","article-title":"Primary hyperparathyroidism in Chinese children and adolescents: a single-centre experience at Peking Union Medical College Hospital","volume":"87","author":"Wang","year":"2017","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:59:50Z","timestamp":1761497990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X23001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1521690X23001276"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101851","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathophysiology of hypophosphatemia","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101851"}}